Liver Fibrosis in Asians With Metabolic Dysfunction–Associated Fatty Liver Disease

2016, EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease, J Hepatol, 64, 1388, 10.1016/j.jhep.2015.11.004 Byrne, 2015, NAFLD: a multisystem disease, J Hepatol, 62, S47, 10.1016/j.jhep.2014.12.012 Eslam, 2020, MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease, Gastroenterology, 158, 1999, 10.1053/j.gastro.2019.11.312 Eslam, 2020, A new definition for metabolic dysfunction–associated fatty liver disease: an international expert consensus statement, J Hepatol, 73, 202, 10.1016/j.jhep.2020.03.039 Tsochatzis, 2014, Liver cirrhosis, Lancet, 383, 1749, 10.1016/S0140-6736(14)60121-5 Choo, 2002, WHO reassesses appropriate body-mass index for Asian populations, Lancet, 360, 235, 10.1016/S0140-6736(02)09512-0 2001, Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486 Mathiesen, 2002, Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases, Dig Liver Dis, 34, 516, 10.1016/S1590-8658(02)80111-6 Hsu, 2019, Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants, Clin Gastroenterol Hepatol, 17, 630, 10.1016/j.cgh.2018.05.059 Wai-Sun Wong, 2021, On the proposed definition of metabolic-associated fatty liver disease, Clin Gastroenterol Hepatol, 19, 865, 10.1016/j.cgh.2021.01.017 Lee, 2021, Metabolic dysfunction–associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study, Clin Gastroenterol Hepatol, 19, 2138, 10.1016/j.cgh.2020.12.022 Bataller, 2005, Liver fibrosis, J Clin Invest, 115, 209, 10.1172/JCI24282 Fattovich, 2008, Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors, J Hepatol, 48, 335, 10.1016/j.jhep.2007.11.011 Vilar-Gomez, 2018, Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study, Gastroenterology, 155, 443, 10.1053/j.gastro.2018.04.034 Chiang, 2011, Obesity, diabetes mellitus, and liver fibrosis, Am J Physiol Gastrointest Liver Physiol, 300, G697, 10.1152/ajpgi.00426.2010 Jarvis, 2020, Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of population-based observational studies, PLoS Med, 17, 10.1371/journal.pmed.1003100 Kowdley, 2012, Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease, Hepatology, 55, 77, 10.1002/hep.24706 Wai-Sun Wong, 2021, Impact of the new definition of metabolic associated fatty liver disease on the epidemiology of the disease, Clin Gastroenterol Hepatol, 19, 2161, 10.1016/j.cgh.2020.10.046 Yun, 2019, Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects, PLoS One, 14, 10.1371/journal.pone.0213692 Wei, 2015, Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using proton-magnetic resonance spectroscopy, Am J Gastroenterol, 110, 1306, 10.1038/ajg.2015.235 Park, 2021, Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease, Aliment Pharmacol Ther, 53, 1030, 10.1111/apt.16324 Ajmera, 2020, Clinical utility of an increase in magnetic resonance elastography in predicting fibrosis progression in nonalcoholic fatty liver disease, Hepatology, 71, 849, 10.1002/hep.30974 Selvaraj, 2021, Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis, J Hepatol, 75, 770, 10.1016/j.jhep.2021.04.044 Hernaez, 2011, Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis, Hepatology, 54, 1082, 10.1002/hep.24452 Hepburn, 2005, The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: a retrospective observational study, BMC Gastroenterol, 5, 14, 10.1186/1471-230X-5-14 Xiao, 2014, Inverse associations of total and decaffeinated coffee with liver enzyme levels in National Health and Nutrition Examination Survey 1999–2010, Hepatology, 60, 2091, 10.1002/hep.27367 Liu, 2022, Estimating global prevalence of metabolic dysfunction–associated fatty liver disease in overweight or obese adults, Clin Gastroenterol Hepatol, 20, e573, 10.1016/j.cgh.2021.02.030 Eslam, 2020, MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease, Gastroenterology, 158, 1999, 10.1053/j.gastro.2019.11.312 Eslam, 2020, A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement, J Hepatol, 73, 202, 10.1016/j.jhep.2020.03.039